Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Epidemiology of extended-spectrum β-lactamase–producing Enterobacterales infection in kidney transplant recipients

View through CrossRef
Abstract Background Extended-spectrum b-lactamase (ESBL)-producing gram-negative bacilli (ESBL-GNB) are the most important pathogenic bacteria infecting kidney transplant patients. Kidney transplantation has been shown to be a risk factor for nosocomial ESBL-GNB bacteremia. The aims of this study were to describe the epidemiology of ESBL-GNB acquisition and to identify factors associated with ESBL-GNB infection in kidney transplant recipients, including pretransplant ESBL-GNB fecal carriage. Methods A prospective study of patients undergoing kidney transplantation at Ramathibodi Hospital from March 1, 2019–November 30, 2020 was conducted. During this period, 66 patients who underwent kidney transplantation. Perianal swab cultures and urine cultures for ESBL-GNB were obtained from all subjects upon admission for transplantation and on Days 3, 7, 14 and 21 after surgery to determine the prevalence, incidence, and duration of admission before acquisition of the organisms. Results Of the 66 patients undergoing kidney transplantation, 18 preoperative perianal swabs were detected to be positive for ESBL-GNB upon admission, representing 27.3% of the cases. The in-hospital perianal swab tests showed a significant increase to 96.8% positive ESBL-GNB cultures at the end of week 3. Approximately one-fourth (27.8%) of patients who acquired ESBL-GNB developed a postoperative symptomatic infection. The infection occurred in 13% of such patients who were not ESBL positive at first. These infections included urinary tract infections (20 cases, [30%], of which 55% were due to ESBL-GNB) and bloodstream infections (13 cases; of which 9 [69.2%] were due to ESBL-GNB). E. coli was the most common pathogen. Previous exposure to antibiotics, including surgical prophylaxis, underlying disease, duration of indwelling urinary catheters and ureteric stents, as well as other operative factors were not found to be significantly associated with the acquisition of ESBL-producing organisms in this dataset. Conclusions ESBL carriage may be a risk factor for the development of bacteremia and other serious infections among kidney transplant recipients, although a statistically significant difference could not be demonstrated owing to the small size of the sample. The high rate of ESBL acquisition suggests that more stringent infection prevention and control efforts are needed.
Title: Epidemiology of extended-spectrum β-lactamase–producing Enterobacterales infection in kidney transplant recipients
Description:
Abstract Background Extended-spectrum b-lactamase (ESBL)-producing gram-negative bacilli (ESBL-GNB) are the most important pathogenic bacteria infecting kidney transplant patients.
Kidney transplantation has been shown to be a risk factor for nosocomial ESBL-GNB bacteremia.
The aims of this study were to describe the epidemiology of ESBL-GNB acquisition and to identify factors associated with ESBL-GNB infection in kidney transplant recipients, including pretransplant ESBL-GNB fecal carriage.
Methods A prospective study of patients undergoing kidney transplantation at Ramathibodi Hospital from March 1, 2019–November 30, 2020 was conducted.
During this period, 66 patients who underwent kidney transplantation.
Perianal swab cultures and urine cultures for ESBL-GNB were obtained from all subjects upon admission for transplantation and on Days 3, 7, 14 and 21 after surgery to determine the prevalence, incidence, and duration of admission before acquisition of the organisms.
Results Of the 66 patients undergoing kidney transplantation, 18 preoperative perianal swabs were detected to be positive for ESBL-GNB upon admission, representing 27.
3% of the cases.
The in-hospital perianal swab tests showed a significant increase to 96.
8% positive ESBL-GNB cultures at the end of week 3.
Approximately one-fourth (27.
8%) of patients who acquired ESBL-GNB developed a postoperative symptomatic infection.
The infection occurred in 13% of such patients who were not ESBL positive at first.
These infections included urinary tract infections (20 cases, [30%], of which 55% were due to ESBL-GNB) and bloodstream infections (13 cases; of which 9 [69.
2%] were due to ESBL-GNB).
E.
coli was the most common pathogen.
Previous exposure to antibiotics, including surgical prophylaxis, underlying disease, duration of indwelling urinary catheters and ureteric stents, as well as other operative factors were not found to be significantly associated with the acquisition of ESBL-producing organisms in this dataset.
Conclusions ESBL carriage may be a risk factor for the development of bacteremia and other serious infections among kidney transplant recipients, although a statistically significant difference could not be demonstrated owing to the small size of the sample.
The high rate of ESBL acquisition suggests that more stringent infection prevention and control efforts are needed.

Related Results

Hepatitis E Viraemia in Transplant Recipients
Hepatitis E Viraemia in Transplant Recipients
Abstract Introduction: Hepatitis E Virus (HEV) is one of the leading causes of acute infectious hepatitis worldwide; while usually a s...
An internet-based expressive writing intervention for kidney transplant recipients
An internet-based expressive writing intervention for kidney transplant recipients
Background: Previous research has found that psychiatric problems and stress in kidney transplant recipients negatively impact upon their quality of life (QOL) and how they heal fr...
The antibody response to COVID-19 among kidney transplant recipients who had PCR confirmed infection
The antibody response to COVID-19 among kidney transplant recipients who had PCR confirmed infection
Introduction Data on antibody response following COVID-19 in kidney transplant recipients is scarce. We performed a cross-sectional study to investigate antibody response to COVID-...

Back to Top